Biotech Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. November 3, 2025
Biotech StimLabs® Announces New Real-World Study Demonstrating Positive Outcomes Using Relese® in the Treatment of Chronic Wounds November 1, 2025
Biotech Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results October 30, 2025
Biotech NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares October 29, 2025
Biotech Kanazawa University Research: Scanning nanoprobe microscope reveals the hidden flexibility of cancer cells October 29, 2025
Biotech FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease October 23, 2025
Biotech SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform October 21, 2025
Biotech FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis October 20, 2025
Search
Biotech
November 3, 2025
November 1, 2025
October 31, 2025
October 30, 2025
October 29, 2025
October 29, 2025
October 26, 2025
October 23, 2025
October 21, 2025
October 20, 2025
